Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KPTI
KPTI logo

KPTI News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KPTI News

Biotech Landscape Update: Regulatory Approvals and Mergers

Mar 27 2026NASDAQ.COM

KPTI Shares Drop in Pre-Market Trading Despite Karyopharm's Myelofibrosis Treatment Achieving Key Goal — Retail Investors Skeptical of FDA Approval

Mar 24 2026stocktwits

Karyopharm Seeks Label Expansion for Xpovio After Positive Trial Results

Mar 24 2026seekingalpha

Karyopharm Therapeutics Secures $30M Private Placement

Mar 24 2026seekingalpha

Karyopharm Reports Significant Results from SENTRY Trial for Myelofibrosis

Mar 24 2026PRnewswire

Karyopharm Secures $30 Million in Private Placement Financing

Mar 24 2026PRnewswire

Karyopharm Secures $30 Million in Private Placement Financing

Mar 24 2026Newsfilter

Wall Street Analysts Adjust Ratings on Key Stocks

Mar 10 2026Benzinga

KPTI Events

No data

No data

KPTI Monitor News

Karyopharm Therapeutics Inc. surges amid market decline

Mar 24 2026

KPTI Earnings Analysis

No Data

No Data

People Also Watch